Wave Life Sciences Ltd. — Director's Dealing 2018

Jun 2, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wave Life Sciences Ltd. (WVE)
CIK: 0001631574
Period of Report: 2018-05-30

Reporting Person: Francis Chris (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-30	Ordinary Shares	M	24496	$2.48	Acquired	46573	Direct
2018-05-30	Ordinary Shares	S	24496	$45.50	Disposed	22077	Direct
2018-06-01	Ordinary Shares	M	24496	$2.48	Acquired	46573	Direct
2018-06-01	Ordinary Shares	S	24496	$48.00	Disposed	22077	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-30	Share Option (right to buy)	$2.48	M	24496	Disposed	2025-03-10	Ordinary Shares (24496)	Direct
2018-06-01	Share Option (right to buy)	$2.48	M	24496	Disposed	2025-03-10	Ordinary Shares (24496)	Direct

Footnotes

F1: The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018.

F2: The share option represented a right to purchase a total of 126,174 ordinary shares, 25% of which became exercisable on April 15, 2015, and the remaining shares vest in 36 equal monthly installments thereafter.